Rafferty Asset Management
FPRX

Rafferty Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Rafferty Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-88,289
Closed -$3.33M – 1295
2021
Q1 		$3.33M Buy
+88,289
New +$2.2M 0.02% 422
2019
Q2 		– Sell
-48,287
Closed -$647K – 869
2019
Q1 		$647K Buy
+48,287
New +$551K 0.01% 622

Rafferty Asset Management's FPRX Position: Q2 2021 in Review

Rafferty Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 88,289 shares — an estimated $3.33M sold.

Rafferty Asset Management first reported a position in FPRX in Q1 2019 and held it in 2 quarters. The position peaked at $3.33M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Rafferty Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 88,289 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $3.33M.
  • Rafferty Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2019 and held it in 2 quarters.
  • Rafferty Asset Management's Five Prime Therapeutics, Inc. position peaked at $3.33M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Rafferty Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.